DNTH - Dianthus Therapeutics, Inc.
NEXT EARNINGS:
Mar 10, 2026
(in 13 days)
EPS Est: $-0.97
|
Rev Est: $448250
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$76.00
DETAILS
HIGH:
$125.00
LOW:
$51.00
MEDIAN:
$62.50
CONSENSUS:
$76.00
UPSIDE:
43.78%
Market Cap:
1.91B
Volume:
558,909
Avg Volume:
771,046
52 Week Range:
13.37-57.5
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.23
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
78
IPO Date:
2018-06-21
EPS (TTM):
-2.55
P/E Ratio:
-8.55
Revenue (TTM):
6.24M
Total Assets:
374.01M
Total Debt:
1.49M
Cash & Equiv:
22.79M
Rev Growth (5Y):
61.7%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-28.6%
Debt/Equity:
0.00
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $-0.97 | $-0.86 | -12.8% | $396000 | $398090 | -0.5% |
| 2025-08-07 | $-0.88 | $-0.86 | -2.3% | $193000 | $864670 | -77.7% |
| 2025-05-12 | $-0.82 | $-0.86 | +4.7% | $1.2M | $806900 | +44.1% |
| 2025-03-11 | $-0.81 | $-0.85 | +4.7% | $1.3M | $955222 | +38.8% |
| 2024-11-07 | $-0.74 | $-0.59 | -25.4% | $2.2M | $844110 | +157.3% |
| 2024-08-08 | $-0.51 | $-0.50 | -2.0% | $1.9M | $320000 | +482.2% |
| 2024-05-09 | $-0.54 | $-0.43 | -25.6% | $874000 | $460000 | +90.0% |
| 2024-03-21 | $-0.71 | $-1.11 | +36.0% | $457000 | $310000 | +47.4% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.24M | 2.83M | 6.42M | 1.48M | 0 | 0 | 0 | 0 | 0 |
| Net Income | (84.97M) | (43.55M) | (28.48M) | (13.11M) | (74.94M) | (76.77M) | (57.52M) | (35.49M) | (9.43M) |
| EPS | -2.55 | -8.45 | -7.60 | -3.82 | -27.30 | -33.18 | -27.62 | -16.05 | -4.27 |
| Total Assets | 374.01M | 179.41M | 83.11M | 189.93M | 161.62M | 161.51M | 157.31M | 54.46M | 11.34M |
| Total Debt | 1.49M | 585,000 | 788,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 22.79M | 132.32M | 15.37M | 131.65M | 58.15M | 65.07M | 58.34M | 51.57M | 4.54M |
| Operating Cash Flow | (78.18M) | (36.86M) | (29.07M) | (59.53M) | (64.02M) | (57.10M) | (41.89M) | (22.26M) | (6.53M) |
| Free Cash Flow | (78.28M) | (36.97M) | (29.21M) | (60.80M) | (64.42M) | (60.16M) | (49.56M) | (24.46M) | (6.67M) |
| FCF per Share | -2.35 | -7.17 | -7.79 | -17.70 | -23.47 | -26.01 | -23.80 | -11.07 | -3.02 |
| Book Value | 352.48M | 168.87M | 73.66M | 172.67M | 143.91M | 141.19M | 145.65M | 50.32M | 9.04M |
| Cash & ST Investments | 275.24M | 173.72M | 75.49M | 176.93M | 148.84M | 145.73M | 142.57M | 51.57M | 4.54M |
| ROC Equity | -0.24 | -0.26 | -0.39 | -0.08 | -0.52 | -0.54 | -0.39 | -0.71 | -1.04 |